UP Strategic Wealth Investment Advisors’s Gilead Sciences GILD Stock Holding History

UP Strategic Wealth Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$630K	Buy	4,700 +243	+5%	+$34K	0.4%	41
2025 Q4	$680K	Hold	4,457	–	–	0.49%	30
2025 Q3	$527K	Sell	4,457 -8	-0.2%	-$909	0.4%	41
2025 Q2	$495K	Sell	4,465 -559	-11%	-$59.5K	0.39%	43
2025 Q1	$563K	Buy	5,024 +180	+4%	+$18.6K	0.5%	38
2024 Q4	$447K	Buy	4,844 +241	+5%	+$21.7K	0.45%	40
2024 Q3	$386K	Buy	+4,603	New	+$351K	0.43%	43

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

UP Strategic Wealth Investment Advisors's GILD Position: Q1 2026 in Review

UP Strategic Wealth Investment Advisors increased its Gilead Sciences (GILD) stake by 5.5% in Q1 2026, buying an estimated $34K and bringing the position to 4,700 shares worth $630K. The position accounts for 0.4% of the portfolio, ranked #41.

UP Strategic Wealth Investment Advisors first reported a position in GILD in Q3 2024 and has held it in 7 quarters since. The position peaked at $680K in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

UP Strategic Wealth Investment Advisors held 4,700 shares of Gilead Sciences worth $630K as of Q1 2026.
UP Strategic Wealth Investment Advisors bought 243 Gilead Sciences shares in Q1 2026, an estimated $34K.
Gilead Sciences made up 0.4% of UP Strategic Wealth Investment Advisors's portfolio in Q1 2026, its #41 holding.
UP Strategic Wealth Investment Advisors first reported a position in Gilead Sciences in Q3 2024 and has held it in 7 quarters since.
UP Strategic Wealth Investment Advisors's Gilead Sciences position peaked at $680K in Q4 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on UP Strategic Wealth Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.